Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | FULCFulcrum Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | −100.0% |
| Net income | $74.88M |
| Net income, yoy | −670.0% |
| Net margin | — |
| Free cash flow | $60.38M |
| FCF margin | — |
| EPS, diluted | $1.18 |
Add another company.